BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Loss of ≥ 15 letters BCVA at 1 year · proliferative diabetic retinopathy
Central PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters ‐ 1 year compared with peripheral PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
Central PRP showed no clear difference in BCVA: gain of 15 or more ETDRS letters ‐ 1 year compared with peripheral PRP (low certainty).
1 finding from 1 review
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
Centre sparing PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters compared with full scatter PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: loss of 15 or more ETDRS letters · people with diabetic retinopathy
Extended targeted PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters: compared with standard PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · people with diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes BCVA: loss of 15 or more ETDRS letters compared with argon laser (very low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes BCVA: gain of 15 or more ETDRS letters compared with argon laser (very low certainty).
1 finding from 1 review
Participation in activities of daily living:individual goal setting Measured by: GAS (up to 5 functional goals scored on a 5‐point scale (−2 = much less than expected to +2 = much more than expected); higher score = better than expected outcome) · children with dystonic cerebral palsy
1 finding from 1 review
no estimate extracted
16 participants
Low
'Treatment failure': various secondary procedures such as remanipulation for early loss of position; early or more complex wire removal ( · children with displaced distal radius fracture with intact or involved or displaced ulna fracture (both‐bone fracture)
It is very uncertain whether summary of findings. Surgery (percutaneous wire fixation) changes 'Treatment failure': various secondary procedures such as… compared with not surgery (cast only) (very low certainty).
1 finding from 1 review
Serious adverse events (typically more serious complications) ( · children with displaced distal radius fracture with intact or involved or displaced ulna fracture (both‐bone fracture)
It is very uncertain whether summary of findings. Surgery (percutaneous wire fixation) changes serious adverse events (typically more serious complications) ( compared with not surgery (cast only) (very low certainty).
1 finding from 1 review
Feeding with more than 50% breast milk (days) · preterm infants
1 finding from 1 review
NEC ≥ stage II · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant‐reported sleep problems (scale: 0 to 28; higher scores indicate more sleep problems) · adults with fibromyalgia
Mirtazapine showed no clear difference in participant‐reported sleep problems (scale: 0 to 28; higher scores… compared with placebo (low certainty).
1 finding from 1 review
Maternal blood loss of 500 mL or greater · women with primary postpartum haemorrhage following vaginal or caesarean birth
Standard care plus IV tranexamic acid may leads to lower blood loss 500 mL or more after randomisation compared with placebo or standard care alone (low certainty).
1 finding from 1 review
Tinnitus loudness · patients with subjective idiopathic tinnitus
1 finding from 1 review
Change in tinnitus loudness measured by a visual analogue scale (range 0 to more than 10) · patients with subjective idiopathic tinnitus
1 finding from 1 review
Interruptions to cancer treatment (unscheduled radiotherapy breaks of 5 or more days) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in interruptions to cancer treatment (unscheduled radiotherapy breaks… compared with placebo; GRADE not reported.
1 finding from 1 review
Back pain · Subacute low back pain
1 finding from 1 review